GNLX
GENELUX CorpCompany with tickers: GNLX
CIK
1231457
CUSIP
36870H103
Shares Outstanding
44,840,416
13F Activity (30d)
58 filings
55 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-11 | Yu Yong |
SVP, Clinical Development | Sell | 605 |
| 2026-05-11 | Zindrick Thomas |
President and CEO | Sell | 2,798 |
| 2026-05-11 | Cappello Joseph |
Chief Technical Officer | Sell | 605 |
| 2026-05-11 | Smalling Ralph |
Head of Regulatory | Sell | 270 |
| 2026-03-25 | Smalling Ralph |
Head of Regulatory | Sell | 240 |
| 2026-03-24 | Cappello Joseph |
Chief Technical Officer | Sell | 906 |
| 2026-03-24 | Zindrick Thomas |
President and CEO | Sell | 3,582 |
| 2026-03-24 | Smalling Ralph |
Head of Regulatory | Sell | 345 |
| 2026-03-24 | Yu Yong |
SVP, Clinical Development | Sell | 906 |
| 2026-03-02 | Thomas John |
Director | Sell | 10,000 |
| 2026-01-02 | Litten Jason |
Chief Medical Officer | Award | 275,000 |
| 2026-01-02 | Litten Jason |
Chief Medical Officer | Other | 0 |
| 2025-12-05 | Smalling Ralph |
Head of Regulatory | Sell | 165 |
| 2025-12-01 | Thomas John |
Director | Sell | 10,000 |
| 2025-11-17 | Zindrick Thomas |
President and CEO | Sell | 4,509 |
| 2025-11-17 | Cappello Joseph |
Chief Technical Officer | Sell | 973 |
| 2025-11-17 | Smalling Ralph |
Head of Regulatory | Sell | 343 |
| 2025-11-17 | Yu Yong |
SVP, Clinical Development | Sell | 973 |
| 2025-09-03 | Smalling Ralph |
Head of Regulatory | Sell | 580 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Award | 925,000 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Other | 16,666 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Other | 925,000 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Award | 157,372 |
| 2025-09-01 | Yu Yong |
SVP, Clinical Development | Other | 65,000 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Award | 23,568 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Other | 65,000 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Other | 23,568 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Other | 13,333 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Award | 13,333 |
| 2025-09-01 | Yu Yong |
SVP, Clinical Development | Other | 207,652 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Other | 80,000 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Other | 250,000 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Other | 157,372 |
| 2025-09-01 | Yu Yong |
SVP, Clinical Development | Award | 65,000 |
| 2025-09-01 | Yu Yong |
SVP, Clinical Development | Award | 207,652 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Award | 65,000 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Award | 16,666 |
| 2025-09-01 | Cappello Joseph |
Chief Technical Officer | Award | 80,000 |
| 2025-09-01 | Smalling Ralph |
Head of Regulatory | Other | 8,333 |
| 2025-09-01 | Smalling Ralph |
Head of Regulatory | Award | 10,000 |
| 2025-09-01 | Smalling Ralph |
Head of Regulatory | Award | 8,333 |
| 2025-09-01 | Zindrick Thomas |
President and CEO | Award | 250,000 |
| 2025-08-27 | Smalling Ralph |
Head of Regulatory | Award | 34,770 |
| 2025-08-27 | Yu Yong |
SVP, Clinical Development | Award | 134,520 |
| 2025-08-27 | Thomas John |
Director | Award | 28,576 |
| 2025-08-27 | Mirabelli Mary |
Director | Award | 22,283 |
| 2025-08-27 | Cappello Joseph |
Chief Technical Officer | Award | 107,500 |
| 2025-08-27 | Zindrick Thomas |
President and CEO | Award | 361,200 |
| 2025-08-27 | Tyree James L |
Director | Award | 22,283 |
| 2025-08-27 | Smither John W |
Director | Award | 28,576 |
Showing 1–50 of 429 transactions